Inaugural Scientific Advisory Board Summit JV Pharma Collaboration Initiative
NEW YORK, NY--(Marketwired - November 04, 2015) - Cell Source, Inc. (OTCQB: CLCS) a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine, announced their initiative for joint venture Pharma …